Similar articles

• Pemetrexed and cisplatin for malignant pleural mesothelioma: a new standard of care?

  Rusch VW. Rusch VW. J Clin Oncol. 2003 Jul 15;21(14):2629-30. doi: 10.1200/JCO.2003.02.043. J Clin Oncol. 2003. PMID: 12860935 No abstract available.
• A pathological complete response in malignant pleural mesothelioma after combination chemotherapy with Carboplatin and pemetrexed.

  Kao SC, McCaughan B, Muljono A, Boyer M. Kao SC, et al. J Thorac Oncol. 2010 Mar;5(3):405-6. doi: 10.1097/JTO.0b013e3181c8cb16. J Thorac Oncol. 2010. PMID: 20186029 No abstract available.
• Pemetrexed-cisplatin combination in mesothelioma.

  Reck M, Gatzemeier U. Reck M, et al. Expert Rev Anticancer Ther. 2005 Apr;5(2):231-7. doi: 10.1586/14737140.5.2.231. Expert Rev Anticancer Ther. 2005. PMID: 15877521 Review.
• [Malignant pleural mesothelioma: further options].

  van Hezik EJ. van Hezik EJ. Arch Bronconeumol. 2005 Dec;41(12):703. doi: 10.1016/s1579-2129(06)60339-x. Arch Bronconeumol. 2005. PMID: 16373048 Spanish. No abstract available.
• Novel combinations using pemetrexed in malignant mesothelioma.

  Gadgeel SM, Pass HI. Gadgeel SM, et al. Clin Lung Cancer. 2004 Apr;5 Suppl 2:S61-6. doi: 10.3816/clc.2004.s.005. Clin Lung Cancer. 2004. PMID: 15117427 Review.